An immunophenotypic and molecular diagnosis of composite hairy cell leukaemia and chronic lymphocytic leukaemia

2013 ◽  
Vol 30 (4) ◽  
Author(s):  
Stuart Liptrot ◽  
David O’ Brien ◽  
Stephen E. Langabeer ◽  
Fiona Quinn ◽  
A. Jill Mackarel ◽  
...  
1998 ◽  
Vol 30 (1-2) ◽  
pp. 203-209 ◽  
Author(s):  
S. A. Brown ◽  
Julia Phillips ◽  
G. Ahsan ◽  
N. G. P. Slater

2015 ◽  
Vol 174 (2) ◽  
pp. 329-331 ◽  
Author(s):  
Marzia Cavalli ◽  
Caterina Ilari ◽  
Ilaria Del Giudice ◽  
Marilisa Marinelli ◽  
Irene Della Starza ◽  
...  

Author(s):  
Drew Provan ◽  
Trevor Baglin ◽  
Inderjeet Dokal ◽  
Johannes de Vos ◽  
Hassan Al-Sader

Acute myeloblastic leukaemia (AML) - Acute lymphoblastic leukaemia (ALL) - Chronic myeloid leukaemia (CML) - Chronic lymphocytic leukaemia (B-CLL) - Prolymphocytic leukaemia (PLL) - Hairy cell leukaemia and variant - Large granular lymphocyte leukaemia (LGLL) - Adult T-cell leukaemia-lymphoma (ATLL)


1986 ◽  
Vol 1 (2) ◽  
pp. 101-104 ◽  
Author(s):  
Marco Chilosi ◽  
Giovanni Pizzolo ◽  
Gianpietro Semenzato ◽  
Gian Luigi Cetto

The sera of patients with hairy cell leukaemia (HCL) contain a factor which inhibits the binding of anti-IL-2R antibody to its target (activated T lymphocytes). The presence of this factor, which probably corresponds to the soluble form of IL-2R (sIL-2R), can be easily detected using a simple immunocytochemical inhibition assay. In a series of patients with chronic lymphoproliferative diseases the presence of sIL-2R appeared to be specific for HCL, using the sensitivity of our test, since it could not be detected in sera from normal subjects and patients with B-cell lymphocytic leukaemia or Hodgkin's disease. Thus it might be used as an additional tool for characterizing HCL patients.


Author(s):  
Drew Provan ◽  
Trevor Baglin ◽  
Inderjeet Dokal ◽  
Johannes de Vos

Acute myeloblastic leukaemia (AML) - Acute lymphoblastic leukaemia (ALL) - Chronic myeloid leukaemia (CML) - Chronic lymphocytic leukaemia (B-CLL) - Prolymphocytic leukaemia (PLL) - Hairy cell leukaemia and variant - Large granular lymphocyte leukaemia (LGLL) - Adult T-cell leukaemia-lymphoma (ATLL)


2016 ◽  
pp. 754-781
Author(s):  
Hemant Malhotra ◽  
Lalit Kumar ◽  
Pankaj Malhotra ◽  
Devendra Hiwase ◽  
Ravi Bhatia

Chronic Leukaemia, as contrasted to the acute luekemia, are slowly growing clonal malignancies of the hematopoietic system in which, even without active intervention, survival is possible for several years. In the past decade there have been several advances in the basic understanding of these diseases which have lead to improvement in survival of several decades in the majority of patients which is now being referred to as ‘operational cure’. This chapter covers the chronic leukaemias (chronic myeloid leukaemia (CML), chronic lymphocytic leukaemia (CLL), hairy cell leukaemia, prolymphocytic leukaemia, large granular lymphocytic leukaemia (LGL), and hairy cell leukaemia variant (HCL-v), including epidemiology, staging and diagnosis, molecular biology, pathology, medical management, disease monitoring, management of relapse/refraction, and future directions.


Sign in / Sign up

Export Citation Format

Share Document